genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Cancer
Poor Lung Cancer Response to Immunotherapy Linked to Commensal Bacteria, Suppressed…
Animal Models
How Well Do Mouse Models Mimic Human Disease?
GPCRs
IPO Raises $161M for GPCR-Based Drug Developer Structure Therapeutics
Immunology
How Signaling Molecules of the Immune System Protect against Disease
Cancer
Changing Carcinogenic Cells in the Lungs with Novel Technology
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
Spatial Biology
Spatial Biology Current State of the Art and What’s Coming Next
Spatial Biology
GEN Interview with Joseph M. Beechem, PhD, Chief Scientific Officer of…
Spatial Biology
Choosing the Right Spatial Technology
Spatial Biology
Spatial and NGS Dominate Proceedings at AGBT 2022
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Home
Bristol-Myers Squibb
Bristol-Myers Squibb
10x Genomics
A-Lists
AgBio
Age-Related Disorders
Aging
AGTC
alcohol
Alexandria Real Estate Equities
Allergic Diseases
Application Notes
Artificial Intelligence
Autoimmune Disorders
Bacterial Diseases
Bacteriophage
Base Editing
Bayer
Biodefense/Bioterrorism
Bioethics
Biomarker Discovery
BioNTech
BioPerspectives
Blockchain
Blood Disorders
Boehringer Ingelheim
Bone disorders
Brexit
Bristol-Myers Squibb
Cardiovascular Disease
Careers
Celgene
Cell Analysis
Cell Biology
Cell Culture
Cell Line Development
Cell Signaling
Cell Therapy
Cellular Analysis
China
Chromatography
Circadian Rhythm
Commentary
Compound Synthesis
Computational Biology
Computer Simulation
COVID-19 Candidates
CRISPR
CRISPR/Cas9
Danaher
Developmental Disorders
DNA Repair
Drug Resistance
Ear Disorders
Economic development
Education and training
Electrophoresis
Eli Lilly
Employment Trends
Endocrine Disorders
Evolution
Extracellular Matrix
Eye Disorders
Fill and Finish
Financing
Flow Cytometry
Forensics
Fungal Diseases
Gastrointestinal Disorders
GEN 40
GEN Edge
Genentech
Genetic Disease Testing
Genetics
Glycan Analysis
Glycoproteins
GWAS
Hematologic Conditions
Histology
HPLC
Hypertension
Imaging
Immunoassay
Immunochemistry
Immunology
In-vitro Fertilization
Industry News
Inflammatory Diseases
Information Management
Insights
interleukin
Ion Channels
Kidney Diseases
Kinases
Literature Review
Liver Diseases
Lung Cancer
Lung Diseases
Magazine
Marijuana
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Financing
EY Eyes Comeback for Biopharma M&A
Immuno-oncology
Cancer I-O Pioneer, Executive Target Immune Disruption with $65M Startup
Cell Therapy
BMS, Immatics Launch Up-to-$4.2B Expanded Cancer Cell Therapy Collaboration
Drug Discovery
Nektar Eliminates 70% of Workforce, 500+ Jobs, in Restructuring
Immuno-oncology
StockWatch: Checkmate Shares Quadruple on Regeneron Buyout
Immuno-oncology
Regeneron to Acquire Checkmate for $250M, Expanding Cancer I/O Pipeline
Cancer
Cardinal CIN: Volastra, BMS Commence Up-to-$1.13B Cancer Collaboration
Gastrointestinal Disorders
Inflection Point: Abivax Challenges Pharma Giants in Ulcerative Colitis
Bristol-Myers Squibb
Bristol-Myers Squibb to Acquire MyoKardia for $13.1B, Expanding Cardiovascular Franchise
Bristol-Myers Squibb
Amgen Eyes Inflammatory Disease Expansion with Planned $13.4B Purchase of Celgene’s...
Bristol-Myers Squibb
Celgene Scraps $2.6B Deal, Licenses Jounce Antibody in Restructured Cancer Collaboration
Bristol-Myers Squibb
BMS Selling Celgene’s Otezla to Address FTC “Concerns” on $74B Deal
Bristol-Myers Squibb
Catalent Acquires BMS Manufacturing Plant in Italy, Expanding Biologics Operations
Scroll Up
Login
Subscribe